Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: cardiovascular failure/Sudden cardiac death; cardiovascular failure/Sudden cardiac death; COVID-19; COVID-19; Viral infection of the respiratory tract; This is a spontaneous report from a non-contactable consumer downloaded from the Medicines Agency (MA) -WEB, regulatory authority number DE-PEI-CADR2021044779, Safety Report Unique Identifier DE-PEI-202100032482. A 74-year-old female patient received bnt162b2 (Pfizer vaccine, Solution for injection), intramuscular on 24Feb2021 (Lot Number: EP9598) as single dose for covid-19 immunisation. Medical history included ongoing Chronic renal insufficiency, ongoing Coronary heart disease, ongoing Arterial hypertension, ongoing Type 2 diabetes mellitus. The patient''s concomitant medications were not reported. The patient''s weight was 72 kg, and height was 156 cm. On 08Mar2021, the patient experienced Viral infection of the respiratory tract, COVID-19. On 09Mar2021, the patient experienced cardiovascular failure/Sudden cardiac death. The patient died on 09Mar2021. No autopsy was performed. It was reported that Information on risk factors or previous illnesses arterial hypertension, coronary heart disease, Diabetes mellitus type 2, chronic renal insufficiency / one day before death in general. physical weakness, Pulmo exacerbated vesicular breathing. No concerned have any allergies. Relatedness of drug to reactions was assessed as D. Unclassifiable by PEI. The outcome of the events cardiovascular failure/Sudden cardiac death was fatal, of the other events was not recovered. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: cardiovascular failure; Sudden cardiac death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166